在两名患有免疫性血小板减少症且有生活方式限制的儿童临床出血发作前积极使用艾曲泊帕。
Proactive use of eltrombopag before the onset of clinical bleeding in two children with immune thrombocytopenia and lifestyle restrictions.
作者信息
Bergmann Shayla
机构信息
Department of Pediatric Hematology/Oncology Medical University of South Carolina 135 Rutledge Avenue MSC 558 Charleston 29425 South Carolina.
出版信息
Clin Case Rep. 2017 Sep 1;5(10):1660-1663. doi: 10.1002/ccr3.1086. eCollection 2017 Oct.
Abstract
Children with immune thrombocytopenia (ITP) are often managed using a watch-and-wait approach to avoid conventional treatment that may be poorly tolerated. However, in some patients, this approach may lead to lifestyle restrictions due to risk of injury-related bleeding. Eltrombopag is a well-tolerated new option that may help these children.
摘要
患有免疫性血小板减少症（ITP）的儿童通常采用观察等待的方法进行治疗，以避免使用耐受性可能较差的传统治疗方法。然而，在一些患者中，由于存在与损伤相关的出血风险，这种方法可能会导致生活方式受到限制。艾曲泊帕是一种耐受性良好的新选择，可能对这些儿童有所帮助。
Zotero 插件